Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Molecular Diagnostics in Cancer Testing
Revenue, means the sales value of Molecular Diagnostics in Cancer Testing
This report studies Molecular Diagnostics in Cancer Testing in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Abbott Molecular Diagnostics
Accugenomics
Agendia
Ambry Genetics
Biodesix
bioMerieux
bioTheranostics (AviaraDx)
Cancer Genetics
Clarient, Inc. (GE Healthcare)
Counsyl
Flatiron Health
Epigenomics
Exact Sciences Corporation
Exiqon
Genomic Health
Genoptix (Novartis)
Genmark Diagnostics
Genomictree
HTG Molecular Diagnostics
Invitae
LabCorp
Myriad Genetics
Nanostring
Neogenomics
NSTG
Nuvera Biosciences
Orion Genomics
Pathway Genomics
Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by Application, this report focuses on consumption, market share and growth rate of Molecular Diagnostics in Cancer Testing in each application, can be divided into
Application 1
Application 2
China Molecular Diagnostics in Cancer Testing Market Research Report 2017
1 Molecular Diagnostics in Cancer Testing Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics in Cancer Testing
1.2 Molecular Diagnostics in Cancer Testing Segment by Type
1.2.1 China Production Market Share of Molecular Diagnostics in Cancer Testing Type in 2015
1.2.2 Type I
1.2.3 Type II
1.3 Applications of Molecular Diagnostics in Cancer Testing
1.3.1 Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.4 China Market Size (Value) of Molecular Diagnostics in Cancer Testing (2012-2022)
1.5 China Molecular Diagnostics in Cancer Testing Status and Outlook
1.6 Government Policies
2 China Molecular Diagnostics in Cancer Testing Market Competition by Manufacturers
2.1 China Molecular Diagnostics in Cancer Testing Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Molecular Diagnostics in Cancer Testing Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Molecular Diagnostics in Cancer Testing Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Molecular Diagnostics in Cancer Testing Manufacturing Base Distribution, Sales Area, Product Type
2.5 Molecular Diagnostics in Cancer Testing Market Competitive Situation and Trends
2.5.1 Molecular Diagnostics in Cancer Testing Market Concentration Rate
2.5.2 Molecular Diagnostics in Cancer Testing Market Share of Top 3 and Top 5 Manufacturers
3 China Molecular Diagnostics in Cancer Testing Manufacturers Profiles/Analysis
3.1 Abbott Molecular Diagnostics
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Accugenomics
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Agendia
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Agendia Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Ambry Genetics
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Biodesix
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Biodesix Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 bioMerieux
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 bioTheranostics (AviaraDx)
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Cancer Genetics
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Clarient, Inc. (GE Healthcare)
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Counsyl
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Molecular Diagnostics in Cancer Testing Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Counsyl Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Flatiron Health
3.12 Epigenomics
3.13 Exact Sciences Corporation
3.14 Exiqon
3.15 Genomic Health
3.16 Genoptix (Novartis)
3.17 Genmark Diagnostics
3.18 Genomictree
3.19 HTG Molecular Diagnostics
3.20 Invitae
3.21 LabCorp
3.22 Myriad Genetics
3.23 Nanostring
3.24 Neogenomics
3.25 NSTG
3.26 Nuvera Biosciences
3.27 Orion Genomics
3.28 Pathway Genomics
4 China Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Molecular Diagnostics in Cancer Testing Capacity, Production and Growth (2012-2017)
4.2 China Molecular Diagnostics in Cancer Testing Revenue and Growth (2012-2017)
4.3 China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import (2012-2017)
5 China Molecular Diagnostics in Cancer Testing Production, Revenue (Value), Price Trend by Type
5.1 China Molecular Diagnostics in Cancer Testing Production and Market Share by Type (2012-2017)
5.2 China Molecular Diagnostics in Cancer Testing Revenue and Market Share by Type (2012-2017)
5.3 China Molecular Diagnostics in Cancer Testing Price by Type (2012-2017)
5.4 China Molecular Diagnostics in Cancer Testing Production Growth by Type (2012-2017)
6 China Molecular Diagnostics in Cancer Testing Market Analysis by Application
6.1 China Molecular Diagnostics in Cancer Testing Consumption and Market Share by Application (2012-2017)
6.2 China Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries
7 ChinaMolecular Diagnostics in Cancer Testing Market Analysis by Regions (Provinces)
7.1 China Molecular Diagnostics in Cancer Testing Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Molecular Diagnostics in Cancer Testing Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Molecular Diagnostics in Cancer Testing Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Molecular Diagnostics in Cancer Testing Sales Price by Regions (Provinces)(2012-2017)
7.2 China Molecular Diagnostics in Cancer Testing Consumption by Regions (Provinces)(2012-2017)
7.3 China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import (2012-2017)
8 Molecular Diagnostics in Cancer Testing Manufacturing Cost Analysis
8.1 Molecular Diagnostics in Cancer Testing Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Molecular Diagnostics in Cancer Testing Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 China Molecular Diagnostics in Cancer Testing Market Forecast (2017-2022)
12.1 China Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Molecular Diagnostics in Cancer Testing Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Molecular Diagnostics in Cancer Testing Production Forecast by Type (2017-2022)
12.4 China Molecular Diagnostics in Cancer Testing Consumption Forecast by Application (2017-2022)
12.5 China Molecular Diagnostics in Cancer Testing Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Molecular Diagnostics in Cancer Testing Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Molecular Diagnostics in Cancer Testing Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Molecular Diagnostics in Cancer Testing Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Molecular Diagnostics in Cancer Testing Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Molecular Diagnostics in Cancer Testing
Figure China Production Market Share of Molecular Diagnostics in Cancer Testing by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Table Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure China Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth Rate (2012-2022)
Table China Molecular Diagnostics in Cancer Testing Capacity of Key Manufacturers (2015 and 2016)
Table China Molecular Diagnostics in Cancer Testing Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Molecular Diagnostics in Cancer Testing Capacity of Key Manufacturers in 2015
Figure China Molecular Diagnostics in Cancer Testing Capacity of Key Manufacturers in 2016
Table China Molecular Diagnostics in Cancer Testing Production of Key Manufacturers (2015 and 2016)
Table China Molecular Diagnostics in Cancer Testing Production Share by Manufacturers (2015 and 2016)
Figure 2015 Molecular Diagnostics in Cancer Testing Production Share by Manufacturers
Figure 2016 Molecular Diagnostics in Cancer Testing Production Share by Manufacturers
Table China Molecular Diagnostics in Cancer Testing Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers
Table 2016 China Molecular Diagnostics in Cancer Testing Revenue Share by Manufacturers
Table China Market Molecular Diagnostics in Cancer Testing Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Molecular Diagnostics in Cancer Testing Average Price of Key Manufacturers in 2015
Table Manufacturers Molecular Diagnostics in Cancer Testing Manufacturing Base Distribution and Sales Area
Table Manufacturers Molecular Diagnostics in Cancer Testing Product Type
Figure Molecular Diagnostics in Cancer Testing Market Share of Top 3 Manufacturers
Figure Molecular Diagnostics in Cancer Testing Market Share of Top 5 Manufacturers
Table Abbott Molecular Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table Accugenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Accugenomics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Accugenomics Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table Agendia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agendia Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Agendia Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table Ambry Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ambry Genetics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Ambry Genetics Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table Biodesix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biodesix Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Biodesix Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table bioMerieux Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table bioMerieux Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure bioMerieux Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table bioTheranostics (AviaraDx) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table Cancer Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cancer Genetics Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Cancer Genetics Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table Clarient, Inc. (GE Healthcare) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table Counsyl Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Counsyl Molecular Diagnostics in Cancer Testing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Counsyl Molecular Diagnostics in Cancer Testing Market Share (2012-2017)
Table Flatiron Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Epigenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Exact Sciences Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Exiqon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genomic Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genoptix (Novartis) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genmark Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genomictree Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table HTG Molecular Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Invitae Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LabCorp Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Myriad Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nanostring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Neogenomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NSTG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nuvera Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Orion Genomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pathway Genomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Molecular Diagnostics in Cancer Testing Capacity, Production and Growth (2012-2017)
Figure China Molecular Diagnostics in Cancer Testing Revenue (Million USD) and Growth (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production by Type (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production Share by Type (2012-2017)
Figure Production Market Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)
Figure 2015 Production Market Share of Molecular Diagnostics in Cancer Testing by Type
Table China Molecular Diagnostics in Cancer Testing Revenue by Type (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Molecular Diagnostics in Cancer Testing by Type (2012-2017)
Figure 2015 Revenue Market Share of Molecular Diagnostics in Cancer Testing by Type
Table China Molecular Diagnostics in Cancer Testing Price by Type (2012-2017)
Figure China Molecular Diagnostics in Cancer Testing Production Growth by Type (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Consumption by Application (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Consumption Market Share by Application (2012-2017)
Figure China Molecular Diagnostics in Cancer Testing Consumption Market Share by Application in 2015
Table China Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)
Figure China Molecular Diagnostics in Cancer Testing Consumption Growth Rate by Application (2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production by Regions (Provinces)(2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production Market Share by Regions (Provinces)(2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production Value by Regions (Provinces)(2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Molecular Diagnostics in Cancer Testing Sales Price by Regions (Provinces)(2012-2017)
Table China Molecular Diagnostics in Cancer Testing Consumption by Regions (Provinces)(2012-2017)
Table China Molecular Diagnostics in Cancer Testing Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Molecular Diagnostics in Cancer Testing Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Molecular Diagnostics in Cancer Testing
Figure Manufacturing Process Analysis of Molecular Diagnostics in Cancer Testing
Figure Molecular Diagnostics in Cancer Testing Industrial Chain Analysis
Table Raw Materials Sources of Molecular Diagnostics in Cancer Testing Major Manufacturers in 2015
Table Major Buyers of Molecular Diagnostics in Cancer Testing
Table Distributors/Traders List
Figure China Molecular Diagnostics in Cancer Testing Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Molecular Diagnostics in Cancer Testing Revenue and Growth Rate Forecast (2017-2022)
Table China Molecular Diagnostics in Cancer Testing Production, Import, Export and Consumption Forecast (2017-2022)
Table China Molecular Diagnostics in Cancer Testing Production Forecast by Type (2017-2022)
Table China Molecular Diagnostics in Cancer Testing Consumption Forecast by Application (2017-2022)
Table China Molecular Diagnostics in Cancer Testing Production Forecast by Regions (Provinces)(2017-2022)
Table China Molecular Diagnostics in Cancer Testing Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Molecular Diagnostics in Cancer Testing Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...